[X]Additional symptom, signs and abnormal clinical and laboratory findings classification terms

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17

Androgen deprivation therapy in men with prostate cancer was not associated with changes in clinical pain (BPI), pressure pain thresholds, cold pain tolerance, mechanical pain temporal summation, or c

Effect: null; 0.31; CI: 95% CI = -0.55 to 1.17